EXTON, Pa., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Lungpacer Medical, a neurostimulation company dedicated to developing innovative interventional therapies to free patients from mechanical ventilation (MV ...
MyChesCo on MSN
Lungpacer Medical Secures FDA Approval for AHRF Trial
EXTON, PA — Lungpacer Medical has announced that the U.S. Food and Drug Administration (FDA) has approved an Investigational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback